## Abstract Cell cycle progression beyond the G~1~/S phase transition requires the activation of a transcription complex containing histone nuclear factor P (HiNFโP) and nuclear protein mapped to ataxia telangiectasia (p220^NPAT^) in response to cyclin dependent kinase 2 (CDK2)/cyclin E signaling.
Prohibitin is a cholesterol-sensitive regulator of cell cycle transit
โ Scribed by Pei Dong; Jessica Flores; Kristine Pelton; Keith R. Solomon
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 970 KB
- Volume
- 111
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Cholesterol is essential in establishing most functional animal cell membranes; cells cannot grow or proliferate in the absence of sufficient cholesterol. Consequently, almost every cell, tissue, and animal tightly regulates cholesterol homeostasis, including complex mechanisms of synthesis, transport, uptake, and disposition of cholesterol molecules. We hypothesize that cellular recognition of cholesterol insufficiency causes cell cycle arrest in order to avoid a catastrophic failure in membrane synthesis. Here, we demonstrate using unbiased proteomics and standard biochemistry that cholesterol insufficiency causes upregulation of prohibitin, an inhibitor of cell cycle progression, through activation of a cholesterolโresponsive promoter element. We also demonstrate that prohibitin protects cells from apoptosis caused by cholesterol insufficiency. This is the first study tying cholesterol homeostasis to a specific cell cycle regulator that inhibits apoptosis. J. Cell. Biochem. 111: 1367โ1374, 2010. ยฉ 2010 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
A mathematical model of regulation of the G1-S transition of the mammalian cell cycle has been formulated to organize available experimental molecular-level information in a systematic quantitative framework and to evaluate the ability of this manifestation of current knowledge to calculate correctl
## Abstract Superficial pT1 bladder tumors are characterized by a high risk of recurrence and progression in grade and stage. Few studies provided evidence that loss of adipocyteโfatty acid binding protein (AโFABP) expression was associated with bladder cancer progression. AโFABP is a lipid binding